passages.id: split_6_test_947_passage
passages.type: progene_text
passages.text: Lamivudine recipients were also more likely to undergo HBeAg seroconversion , defined as the loss of HBeAg , undetectable levels of serum HBV DNA , and the appearance of antibodies against HBeAg ( 17 percent vs. 6 percent , P = 0.04 ) .